Aristacare At Manchester
Inspection Findings
F-Tag F0550
Federal health inspectors cited ARISTACARE AT MANCHESTER in MANCHESTER, NJ for a deficiency under regulatory tag F-F0550 during a standard health inspection conducted on 2025-08-27.
Category: Resident Rights Deficiencies
The facility was found deficient in the following area: Honor the resident's right to a dignified existence, self-determination, communication, and to exercise his or her rights.
Scope/Severity Level D: isolated, no actual harm with potential for more than minimal harm.
While no actual harm was documented, there was potential for more than minimal harm to residents.
This was one of 7 deficiencies cited during this inspection of ARISTACARE AT MANCHESTER.
Correction Status: Deficient, Provider has date of correction.
The facility reported correction as of 2025-10-21.
F-Tag F0582
Federal health inspectors cited ARISTACARE AT MANCHESTER in MANCHESTER, NJ for a deficiency under regulatory tag F-F0582 during a standard health inspection conducted on 2025-08-27.
Category: Resident Rights Deficiencies
The facility was found deficient in the following area: Give residents notice of Medicaid/Medicare coverage and potential liability for services not covered.
Scope/Severity Level D: isolated, no actual harm with potential for more than minimal harm.
While no actual harm was documented, there was potential for more than minimal harm to residents.
This was one of 7 deficiencies cited during this inspection of ARISTACARE AT MANCHESTER.
Correction Status: Deficient, Provider has date of correction.
The facility reported correction as of 2025-10-21.
F-Tag F0693
Federal health inspectors cited ARISTACARE AT MANCHESTER in MANCHESTER, NJ for a deficiency under regulatory tag F-F0693 during a standard health inspection conducted on 2025-08-27.
Category: Quality of Life and Care Deficiencies
The facility was found deficient in the following area: Ensure that feeding tubes are not used unless there is a medical reason and the resident agrees; and provide appropriate care for a resident with a feeding tube.
Scope/Severity Level D: isolated, no actual harm with potential for more than minimal harm.
While no actual harm was documented, there was potential for more than minimal harm to residents.
This was one of 7 deficiencies cited during this inspection of ARISTACARE AT MANCHESTER.
Correction Status: Deficient, Provider has date of correction.
The facility reported correction as of 2025-10-21.
F-Tag F0761
Federal health inspectors cited ARISTACARE AT MANCHESTER in MANCHESTER, NJ for a deficiency under regulatory tag F-F0761 during a standard health inspection conducted on 2025-08-27.
Category: Pharmacy Service Deficiencies
The facility was found deficient in the following area: Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted professional principles; and all drugs and biologicals must be stored in locked compartments, separately locked, compartments for controlled drugs.
Scope/Severity Level D: isolated, no actual harm with potential for more than minimal harm.
While no actual harm was documented, there was potential for more than minimal harm to residents.
This was one of 7 deficiencies cited during this inspection of ARISTACARE AT MANCHESTER.
Correction Status: Deficient, Provider has date of correction.
The facility reported correction as of 2025-10-21.
F-Tag F0842
F 0842 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few
FORM CMS-2567 (02/99) Previous Versions Obsolete
[signs/symptoms] of infection every shift for infection. On 2/23/2025 (day) and 2/24/2025 (day) blank spaces were observed.A PO, dated 2/22/2025, to offload heels when in bed every shift for prevention. On 2/23/2025 (day) and 2/24/2025 (day) blank spaces were observed.A PO, dated 2/22/2025, for skin protectant to apply to buttock topically every shift for prevention. On 2/23/2025 (day) and 2/24/2025 (day) blank spaces were observed.A PO, dated 2/22/2025, to record supra pubic cather output every shift for monitoring. On 2/24/2025 (day) a blank space was observed.A PO, dated 2/22/2025, to render suprapubic catheter care every shift for prevention. On 2/24/2025 (day) a blank space was observed.On 8/26/2025 at 8:41 AM, the surveyor interviewed the Licensed Practical Nurse (LPN #1) who stated that upon administered medication and/or treatments the MAR/TAR should be checked off to show that it was given or completed. When asked what a blank box could mean, LPN #1 stated that the medication was not given or the treatment was not completed. On 8/26/2025 at 8:57 AM, the surveyor interviewed the Licensed Nurse Practioner/Unit Manager (LPN/UM) who stated that physicians orders should be carried out as written and that there should never be blanks in the MAR/TAR. When asked what a blank could mean, the LPN/UM responded that it was not done. During an interview on 8/26/2025 at 1:48 AM with the surveyor the Director of Nursing, in the presence of the Licensed Nursing Home Administrator Regional Clinical Director acknowledged that the MAR/TAR should be completed in its entirety upon completion of the order and that if it was not filled in it could mean that the order was not done. A review the undated facility policy titled, Administering Medications revealed the following under Policy Interpretation and Implementation: [ .] 3.
Medications must be administered in accordance with the orders, including any required time frame. [ .] 11.
The individual administering the medication must document in [electronic records] after giving each medication by clicking the Y. [ .] 13. If a drug is withheld, refused, or given at a time other than the scheduled time, the individual administering the medication shall click the N on the EMAR and then document as prompted by PCC. A review the undated facility policy titled, Charting and Documentation revealed the following under Policy Interpretation and Implementation: 1. All observations, medications administered, services performed, etc, must be documented in the resident's clinical record. NJAC 8:3923.2
Event ID:
Facility ID:
If continuation sheet
F-Tag F0880
Federal health inspectors cited ARISTACARE AT MANCHESTER in MANCHESTER, NJ for a deficiency under regulatory tag F-F0880 during a standard health inspection conducted on 2025-08-27.
Category: Infection Control Deficiencies
The facility was found deficient in the following area: Provide and implement an infection prevention and control program.
Scope/Severity Level D: isolated, no actual harm with potential for more than minimal harm.
While no actual harm was documented, there was potential for more than minimal harm to residents.
This was one of 7 deficiencies cited during this inspection of ARISTACARE AT MANCHESTER.
Correction Status: Deficient, Provider has date of correction.
The facility reported correction as of 2025-10-21.
F-Tag F0882
Federal health inspectors cited ARISTACARE AT MANCHESTER in MANCHESTER, NJ for a deficiency under regulatory tag F-F0882 during a standard health inspection conducted on 2025-08-27.
Category: Infection Control Deficiencies
The facility was found deficient in the following area: Designate a qualified infection preventionist to be responsible for the infection prevent and control program in the nursing home.
Scope/Severity Level D: isolated, no actual harm with potential for more than minimal harm.
While no actual harm was documented, there was potential for more than minimal harm to residents.
This was one of 7 deficiencies cited during this inspection of ARISTACARE AT MANCHESTER.
Correction Status: Deficient, Provider has date of correction.
The facility reported correction as of 2025-10-21.
ARISTACARE AT MANCHESTER in MANCHESTER, NJ inspection on recent inspection.
Found 0 violation(s). Severity: Standard violations. Status: 0 corrected, 0 pending.
Frequently Asked Questions
- What is an F-tag violation?
- F-tags are federal deficiency codes used by CMS to categorize nursing home violations. Each F-tag corresponds to a specific federal regulation (42 CFR Part 483). For example, F607 relates to abuse prevention policies, F880 relates to infection control.
- Were these violations corrected?
- Facilities must submit plans of correction and implement changes within required timeframes. CMS conducts follow-up inspections to verify corrections. Check the inspection report for specific correction dates and follow-up verification status.
- How often do nursing home inspections happen?
- CMS conducts unannounced inspections of all Medicare/Medicaid-certified nursing homes at least once per year. Additional inspections may occur based on complaints, facility-reported incidents, or follow-up to verify previous violations were corrected.
- What should families do about these violations?
- Families should: (1) Review the full inspection report for details, (2) Ask facility administration about specific corrective actions taken, (3) Check if this represents a pattern by reviewing prior inspections, (4) Compare with other facilities in MANCHESTER, NJ, (5) Report new concerns to state authorities.
- Where can I see the full inspection report?
- Complete inspection reports are available on Medicare.gov's Care Compare website (www.medicare.gov/care-compare). You can also request copies directly from ARISTACARE AT MANCHESTER or from the state Department of Health. Reports include deficiency codes, facility responses, and correction timelines.